about
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutationUse of the Internet by women with breast cancer.Interpectoral nodes as the initial site of recurrence in breast cancer.Current comprehensive assessment and management of women at increased risk for breast cancer.Allergic reactions to isosulfan blue in sentinel lymph node mapping.Pregnancy-associated breast cancer and increased risk of pregnancy-associated recurrence: a case report.The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancerA Web- and Mobile-Based Intervention for Women Treated for Breast Cancer to Manage Chronic Pain and Symptoms Related to Lymphedema: Randomized Clinical Trial Rationale and ProtocolScreening prior to Breast Cancer Diagnosis: The More Things Change, the More They Stay the Same.Breast Cancer Profile among Patients with a History of Chemoprevention.A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood.Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.Organochlorine compounds (DDE and PCB) in plasma and breast cyst fluid of women with benign breast disease.Oncologic outcomes after nipple-sparing mastectomy: A single-institution experience.Clinical Characteristics in Patients with Triple Negative Breast Cancer.Factors correlating with lymph node metastases in patients with T1 breast cancer.Therapeutic options for Paget's disease: A single institution long-term follow-up study.Pulse oximeter changes with sentinel lymph node biopsy in breast cancer.Predictors of breast cancer development in a high-risk population.Assessing a Bayesian risk prediction model in a high-risk breast cancer population.The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer.Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ.Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.Racial/ethnic differences and potential psychological benefits in use of the internet by women with breast cancer.Internet use and social support in women with breast cancer.Breast Cancer Risk Assessment and Screening in Transgender Patients.The development of interval breast malignancies in patients with BRCA mutations.The relationship of mammographic density and age: implications for breast cancer screening.Free silicone injection causing polyarthropathy and septic shock.The relationship of obesity, mammographic breast density, and magnetic resonance imaging in patients with breast cancer.Cancer risk assessment using genetic panel testing: considerations for clinical application.Immediate breast reconstruction in patients with locally advanced diseaseCohort study of women at risk for breast cancer and gross cystic diseasePost-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal MicrometastasesDuctal carcinoma in situ on core needle biopsy only with no residual disease at surgeryA Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during ExcisionNipple-sparing Mastectomy and Sub-areolar Biopsy: To Freeze or not to Freeze? Evaluating the Role of Sub-areolar Intraoperative Frozen SectionBreast Cancer Risk Factors in Younger and Older Women
P50
Q33811527-FA51E2C1-5E50-4ED8-8637-FC7B47453F7FQ35568683-72A0AD49-4580-460F-9A5D-2233A112BF8DQ35652547-D7FB8FA6-0577-4596-BAD4-BB31B0732915Q35684773-AF827FAA-A97F-454C-A7C5-119597CB933BQ36007460-EAC4CE48-93DD-47AC-9B0F-1D35B8C5B4EFQ36146235-B2329EE9-ACD3-4314-977A-52AABE0F6DABQ36391200-5900B40F-C4D5-44B3-B20A-89F9A3E54F13Q36548023-08A2C554-441F-43B2-9655-B93B6E946622Q37212776-E5FF63FA-0DB8-4D4A-BDCB-C3F54AEC3765Q37547625-F9D8B258-4B49-4C47-9739-EA5E88615C15Q37683529-0C3DE865-7AD1-4F4B-898B-02D9958DF7FAQ38454172-46F93705-D708-4DEB-9A50-3AF94E0F5F7EQ38766523-9CAF05C8-8A05-4AFA-B610-2472D6D8DF75Q39931915-E146BBFF-F6CF-4D9E-A32B-63281FA0EDC7Q40849362-9132990C-EFA7-48FF-961D-CAB90DFC5BB6Q41080412-3575102E-1756-4992-B956-8096BCD042A6Q41623076-3BE191EF-491F-4F98-AB3E-223F761D2453Q43640919-316F9206-6270-438B-B1B9-F26F04AA7743Q43879422-AC2328D2-B249-47BD-BADF-BD7DD7AB0443Q44650356-EC7A46DD-A811-4E1F-8A23-06E7F1EC74DCQ44907972-0C92A427-CA7C-4827-815F-9F1DEF9D7741Q45245688-0A5136C3-C3E1-49FC-A1B1-AC0F0E8DC8A4Q46162590-0365A6FB-F2DB-463F-B56A-5A276831685AQ46910756-BF11BD1C-F916-4906-99B7-FD785CD452D9Q47110043-AB3B9178-8CDB-4203-AB6F-B1F98D3A8537Q47564901-396B95F4-B7B3-471B-A6DF-D06476FC1125Q47569713-F21479FB-199C-4F0B-9E77-5AC82D953E39Q47787652-A1CF72C4-4C02-4781-A488-6388D63ADEC5Q50744015-1A8157DA-9046-4FF9-9344-6F9C68F0C8A2Q50962617-B512E13A-D7CA-43A6-89E3-900BA83D9729Q51703802-ED7BDFF5-2C26-4AE7-A3E2-DE28213E6BFBQ53038896-406503FB-EDD6-4C12-81C0-02FDCCFD8B78Q53292592-ED0E7AB0-C0F3-4D7F-B4EA-466CB565AD25Q57458458-9AB0D967-93F5-44D6-A6FE-642008E07497Q57695953-7439FB10-634E-420E-92EA-8C407603F6C4Q60681785-40BC45DB-CCCF-401C-A2BB-23E0B5FFBEE1Q60682649-B18298D7-FB4B-4198-A758-968980BCCF2AQ60682675-AD38B84E-8291-44CE-B102-70F9832946A8Q60682677-3BE6083E-8355-4AB2-83AD-0CEABE28CCCBQ60682685-2DB0F41E-54D7-4731-BD13-2818640A2CD8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Freya Schnabel
@ast
Freya Schnabel
@en
Freya Schnabel
@es
Freya Schnabel
@nl
Freya Schnabel
@sl
type
label
Freya Schnabel
@ast
Freya Schnabel
@en
Freya Schnabel
@es
Freya Schnabel
@nl
Freya Schnabel
@sl
prefLabel
Freya Schnabel
@ast
Freya Schnabel
@en
Freya Schnabel
@es
Freya Schnabel
@nl
Freya Schnabel
@sl
P106
P21
P31
P496
0000-0002-6393-7453